IGHD5OR15-5A

Across TCGA pan-cancer cohorts, IGHD5OR15-5A RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated IGHD5OR15-5A data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher IGHD5OR15-5A RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IGHD5OR15-5A expression acts as an unfavorable survival marker.

STAD, KIRC, and DLBC are the cancer types where IGHD5OR15-5A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.172	0.558	<.001	45	view →
KIRC	OS	Tertile	All	0.148	0.655	.032	36	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	36	view →
LUSC	OS	Tertile	All	0.003	0.819	<.001	18	view →
SARC	DFS	Tertile	All	0.148	0.613	.007	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

IGHD5OR15-5A–STAD (DFS)

Open the STAD breakdown →